HR 1869 creates a new DOJ task force within the Criminal Division to investigate and prosecute international trade crimes, such as customs evasion, smuggling, and trade-based money laundering. It requires the DOJ to hire specialized prosecutors, coordinate with agencies like U.S. Customs and Border Protection, and focus on specific violations covered under statutes like 18 U.S.C. §§ 541-546 and 21 U.S.C. § 331. The bill authorizes $20 million in funding for fiscal year 2026 (with 80% dedicated to criminal prosecutions), mandates annual reports to Congress on enforcement activities, and requires the DOJ to develop multi-agency partnerships to address these crimes. This directly affects federal prosecutors, border enforcement agencies, and industries impacted by trade violations.
This bill establishes the "INCLUDE Project" at the National Institutes of Health (NIH) to advance research on Down syndrome. It directs NIH to coordinate and expand research into co-occurring health conditions (like Alzheimer's, heart disease, and autoimmune disorders) affecting individuals with Down syndrome, while avoiding duplication of existing efforts. The law requires NIH to build large study populations, support inclusive clinical trials, identify biomarkers, and improve quality of life for people with Down syndrome and their families. NIH must submit biennial reports to Congress detailing research progress and findings. The bill directly affects NIH research programs and future medical care for people with Down syndrome.
National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.
This resolution designates the week of August 22 through August 30, 2026, as "National Park Week." It directly affects the public by encouraging responsible visits and support for the National Park System, which includes parks, battlefields, and historical sites located across the United States and its territories. The measure serves as a formal declaration to highlight the parks' role in recreation, education, and economic activity without altering any laws or funding.
HR 7008, the Stop Insider Trading Act, restricts Members of Congress, their spouses, and dependent children from purchasing certain investments like stocks in publicly traded companies. It requires 7-14 days' advance public notice before selling any such investment, including the sale date, description, and number of shares. Exceptions apply for work-related transactions (e.g., employer compensation) and reinvesting dividends. Violations trigger a fee of $2,000 or 10% of the investment’s value (whichever is greater), plus any net gain, paid from personal funds - not congressional allowances or campaign donations. The bill aims to prevent conflicts of interest by increasing transparency around congressional financial dealings.
This resolution designates the week of August 2 through August 8, 2026, as "National Farmers Market Week" to honor the importance of local food markets. It serves as a symbolic gesture to recognize how these markets support farmers' livelihoods, strengthen local economies, and connect urban and rural communities. The bill does not create new laws or funding but instead formally acknowledges the role farmers markets play in promoting sustainable farming and public health.
HR 4541, the EARLY Act Reauthorization of 2025, extends the funding period for the Young Women’s Breast Health Education and Awareness program. It amends the Public Health Service Act to update the program’s expiration date from 2026 to 2031. The bill directly affects young women aged 15-25 by ensuring continued access to breast health education and awareness resources. The key provision is a simple extension of the existing program’s authorization period, without altering its scope or requirements. This is a procedural reauthorization to maintain current services through 2031.
The NIH IMPROVE Act (HR 6238) establishes a new NIH research initiative focused on improving maternal health outcomes in the U.S. It directly affects pregnant and postpartum women, particularly those in communities experiencing health disparities linked to higher maternal mortality and severe maternal morbidity. The bill authorizes $73.4 million annually (2026-2031) for NIH to fund research targeting preventable causes of maternal deaths, reduce health disparities, and evaluate community-based interventions. Key provisions require NIH to advance evidence-based solutions through grants and studies on biological, behavioral, and regional factors affecting maternal health before, during, and after pregnancy.
This bill reauthorizes funding for the C.W. Bill Young Cell Transplantation Program, setting $31 million for fiscal year 2025 and $33 million annually for fiscal years 2027-2031. It also extends the deadline for the national cord blood inventory program from 2026 to 2031. The legislation directly affects stem cell research programs and cord blood banks by maintaining federal funding levels and prolonging the inventory program’s timeline. These provisions ensure continuity for existing research infrastructure and blood bank operations without introducing new policy changes.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
HR 2913, the Ukraine Support Act, provides comprehensive U.S. support for Ukraine in response to Russia's invasion. The bill authorizes security assistance including lend-lease authority for military equipment, establishes a Ukraine Reconstruction Trust Fund for economic recovery, and imposes new sanctions targeting Russian financial institutions, oil companies, and government officials. It also includes provisions to counter Russian disinformation, support Radio Free Europe, and address the kidnapping of Ukrainian children. The legislation directly affects U.S. foreign policy, Ukraine's defense capabilities, and Russia's access to international financial systems. The act aims to strengthen Ukraine's sovereignty while holding Russia accountable for its actions.
